American healthcare's dirty little secret

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 1, 2012, Pages 1-2

  White, Christopher J ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CAROTID ARTERY STENTING; CATHETERIZATION; CAUSE OF DEATH; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEART MUSCLE REPERFUSION; HUMAN; MEDICARE; PATIENT CARE; STROKE; TREATMENT OUTCOME; UNITED STATES;

EID: 84355166751     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23442     Document Type: Editorial

References (11)

1. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP,. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008; 39: 924-8. (Pubitemid 351619542)
2. Roger VL, Go AS, Lloyd-Jones DM, et al.. Heart Disease and Stroke Statistics-2011 Update: A Report From the American Heart Association. Circulation 2011:CIR.0b013e3182009701.
3. Sacco RL, Benjamin EJ, Broderick JP, et al.. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 1997; 28: 1507-17.
4. Fonarow GC, Smith EE, Saver JL, et al.. Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes. Circulation 2011; 123: 750-758.
5. Fields JD, Khatri P, Nesbit GM, et al.. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. Journal of NeuroInterventional Surgery 2011; 3: 151-155.
6. Levy EI, Siddiqui AH, Crumlish A, et al.. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009; 40: 3552-6.
7. White CJ, Abou-Chebl A, Cates CU, et al.. Stroke intervention catheter-based therapy for acute ischemic stroke. J Am Coll Cardiol 2011; 58: 101-16.
8. Suzuki S, Saver JL, Scott P, et al.. Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am J Neuroradiol 2004; 25: 1802-6. (Pubitemid 44123711)
9. White CJ, Cates CU, Cowley MJ, et al.. Interventional stroke therapy: current state of the art and needs assessment. Catheter Cardiovasc Interv 2007; 70: 471-6. (Pubitemid 350195003)
10. DeVries JT, White CJ, Cunningham MC, Ramee SR,. Catheter-based therapy for acute ischemic stroke: a national unmet need. Catheter Cardiovasc Interv 2008; 72: 705-9.
11. Ramee SR, Dawson R, McKinley KL, et al.. Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv 2001; 52: 457-67. (Pubitemid 32275034)